Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the immune system.

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

Dr. Daniel P. Petrylak discussed recent developments in prostate cancer care, emphasizing the importance of genetic testing and personalized treatment. Dr. Daniel P. Petrylak, a professor of Medicine ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are denied access to abiraterone, and the charity said it will "continue to ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

An Italian oncologic psychologist warns these patients: “A prostatectomy doesn’t cure anxiety.” Emotional distress can be so ...